From F00 l. I think they need to do some more research - nothing about Fragile X, TBI, etc.
2 growing biotech stocks for your portfolio in 2015
By now investors will have come to terms with the fact that in 2014 the gains from the S&P/ASX 200 were nothing short of lacklustre.
Despite the flat result and the less-than-rosy economic outlook for 2015 there are always ‘gems’ to be found on the stock market.
Neuren Pharmaceuticals Ltd
Having gained close to 50% in the last year, Neuren currently trades at 15.5 cents and with a market capitalisation of approximately $250 million. Neuren is hoping to develop a drug to treat Rett syndrome – a disease for which there is currently no cure.
Ready set blast off, page-21
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.09 |
Change
-0.710(3.26%) |
Mkt cap ! $2.693B | |||
| Open | High | Low | Value | Volume |
| $21.74 | $21.78 | $21.03 | $7.303M | 342.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 377 | $21.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.10 | 257 | 1 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$21.16 |
Change
-0.710 ( 3.28 %) |
||||
| Open | High | Low | Volume | ||
| $21.72 | $21.72 | $21.03 | 92331 | ||
| Last updated 15.59pm 17/05/2024 ? | |||||
| NEU (ASX) Chart |